Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Raises $2.1M in Bridge Financing

Premium

OpGen has raised $2.1 million in a securities offering, the company disclosed in a filing with the US Securities and Exchange Commission last week.

The funding round, which had 27 participants, is a bridge financing that will be used to commercialize the Argus Optical Mapping System, the Gaithersburg, Md.-based company told In Sequence's sister publication GenomeWeb Daily News this week. According to the filing, the total size of the round is $2.3 million.

A couple of months ago, the company increased the amount of mapping data the Argus system can produce to 2.5 gigabases per day, making it more useful for the de novo assembly of large genomes. It is also working on a whole-chromosome de novo assembly application to screen for structural variations (IS 10/18/2011).

In a number of demonstration projects, the company has shown that its technology is useful to compare the genomes of different microbial strains, to assist and verify the assembly of microbes, and to help with the assemblies of human, plant, and animal genomes (IS 7/5/2011).

A year ago, OpGen raised $17 million in a Series B financing round, and added another $3 million as part of the same round earlier this year.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.